Can Buying Annovis Bio Inc (NYSE: ANVS) Still Be Worthwhile?

Annovis Bio Inc (NYSE:ANVS) does about 507.37K shares in volume on a normal day but saw 779304 shares change hands in Tuesday’s trading. The company now has a market cap of 92.04M USD. Its current market price is $8.36, marking an increase of 22.04% compared to the previous close of $6.85. The 52 week high reached by this stock is $22.49 whilst the lowest price level in 52 weeks is $4.79.

Annovis Bio Inc (ANVS) has a 20-day trading average at $8.45 and the current price is -62.83% off the 52-week high compared with 74.53% distance from its 52-week low. The 50-day simple moving average of the closing price is $9.74 and its 200-day simple moving average is $10.26. If we look at the stock’s price movements over the week, volatility stands at 20.94%, which increases to 28.93% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 49.88 to suggest the stock is neutral.

The consensus objective for the share price is $32.00, suggesting that the stock has a potential upside of 73.88% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on December 29, 2023 when Canaccord Genuity initiated the stock to “Buy” and issued a price target of $36.

Annovis Bio Inc (ANVS) stock is up 56.26% over the week and -24.62% over the past month. Its price is -55.29% year-to-date and -40.67% over the past year.

The stock last released its quarterly earnings report for quarter ended 12/31/2023, with the company’s earnings per share (EPS) of -1.19 below consensus estimates by -0.86. The company’s next earnings report forecasts estimating quarterly EPS at -0.8 and -2.54 for whole year.

To reach the target analysts have set, the stock logically needs to grow 73.88 percent from here.

The company has a return on equity of -566.49%. The beta has a value of 1.78.